+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
FEMALE
ID07783386

Comparing Different Volumes of Serratus Posterior Superior Intercostal Plane Block Using 0.25% Bupivacaine for Pain Relief After Breast Surgery

Led by Bursa City Hospital · Updated on 2026-08-24

90

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effectiveness of different volumes of serratus posterior superior intercostal plane SPSIP block for managing pain after unilateral breast surgery with axillary lymph node dissection. This study will compare three groups receiving 20 mL, 30 mL, or 40 mL of 0.25% bupivacaine to understand which volume best controls postoperative pain. The trial is randomized and double-blind to ensure reliable comparison among the groups. Participants will receive a single ultrasound-guided SPSIP block before general anesthesia. The local anesthetic will be injected between the serratus posterior superior and intercostal muscles at the T3-T4 level using one of the three volumes of 0.25% bupivacaine. Ninety participants will be assigned to one of these three dosing groups to assess differences in pain control. During the study, researchers will monitor tramadol use in the first 24 hours after surgery as the main outcome. They will also evaluate pain intensity at multiple time points, the time to first pain medication request, use of rescue analgesics, recovery quality, nausea and vomiting, block success, and any complications related to the block. The study is expected to last from March 2026 to February 2027, with participants closely monitored during the immediate postoperative period.

CONDITIONS

Brief Title

Effect of Different Volumes of SPSIP Block in Breast Surgery

Research Team

E

EMRE ULUSOY, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here